C-Jun N-terminal kinase induces axonal degeneration and limits motor recovery after spinal cord injury in mice

► Enhancement of functional recovery by inhibiting JNK after SCI. ► Cell death signal JNK induces axonal degeneration. ► Our data suggest importance of axonal dieback in the pathophysiology of CNS. C-Jun N-terminal kinase (JNK) mediates neuronal death in response to stress and injury in the CNS and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuroscience research 2011-11, Vol.71 (3), p.266-277
Hauptverfasser: Yoshimura, Kazuhiro, Ueno, Masaki, Lee, Sachiko, Nakamura, Yuka, Sato, Akinobu, Yoshimura, Koichi, Kishima, Haruhiko, Yoshimine, Toshiki, Yamashita, Toshihide
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:► Enhancement of functional recovery by inhibiting JNK after SCI. ► Cell death signal JNK induces axonal degeneration. ► Our data suggest importance of axonal dieback in the pathophysiology of CNS. C-Jun N-terminal kinase (JNK) mediates neuronal death in response to stress and injury in the CNS and peripheral nervous system. Here, we show that JNK also regulates retrograde axonal degeneration (axonal dieback) after spinal cord injury (SCI) in mice. Activated phospho-JNK was highly expressed in damaged corticospinal tract (CST) axons after thoracic SCI by hemisection. Local administration of SP600125, a JNK inhibitor, prevented accumulation of amyloid-β precursor protein and retraction of the severed CST axons as well as preserved the axonal arbors rostral to the injury site. The treatment with SP600125 also improved functional recovery of the hindlimbs, assessed by Basso mouse scale open-field scores and the grid-walking test. In Jnk1 −/− and Jnk3 −/− mice, we observed prevention of axonal degeneration and enhancement of motor recovery after SCI. These results indicate that both JNK1 and JNK3 induce axonal degeneration and limit motor recovery after SCI. Thus, a JNK inhibitor may be a suitable therapeutic agent for SCI.
ISSN:0168-0102
1872-8111
DOI:10.1016/j.neures.2011.07.1830